ACP
VCEL icon

Acuta Capital Partners’s Vericel Corp VCEL Stock Holding History

Acuta Capital Partners’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-190,055
Closed -$1.84M – 49
2018
Q2 		$1.84M Buy
+190,055
New +$2.37M 0.33% 42

Other funds holding VCEL

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Acuta Capital Partners's VCEL Position: Q3 2018 in Review

Acuta Capital Partners sold out of Vericel Corp (VCEL) in Q3 2018, closing a stake of 190,055 shares — an estimated $1.84M sold.

Acuta Capital Partners first reported a position in VCEL in Q2 2018 and held it in 1 quarter. The position peaked at $1.84M in Q2 2018. 132 funds tracked by Wall St. Rank hold VCEL as of Q3 2018.

  • Acuta Capital Partners reported no remaining Vericel Corp position as of Q3 2018 after selling out during the quarter.
  • Acuta Capital Partners sold 190,055 Vericel Corp shares in Q3 2018, an estimated $1.84M.
  • Acuta Capital Partners first reported a position in Vericel Corp in Q2 2018 and held it in 1 quarter.
  • Acuta Capital Partners's Vericel Corp position peaked at $1.84M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2018.

Based on Acuta Capital Partners's 13F filing for Q3 2018, filed 7 Nov 2018.